Visionary Venture Partners

Visionary Ventures is a private venture capital firm focused on life sciences, with particular emphasis on ophthalmology and medical aesthetics. The firm invests from early-stage Series A through later-stage commercialization rounds and typically targets investments in the $5 million to $15 million range. Its model is differentiated by the use of a network of key opinion leaders, especially ophthalmologists, to source, evaluate, and support portfolio companies. Visionary backs both therapeutics and medical device companies rather than developing products internally. Its portfolio has included companies in ocular cell therapy, retinal disease, presbyopia, glaucoma, cataract surgery, and sustained-release ophthalmic drug delivery.